EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient-Reported Barriers To Antidepressant Adherence Among Young Adults With Major Depressive Disorder: A Narrative Review

Dr. Neha K, Dr Anjana Farswan, Dr. Ranjana Singh, Dr. Raskirat Kaur, Dr. Meenakshi

Adolescência e Saúde · 17.08.2026 · 21 (6s) · 36-41

DOI: 10.67440/ahj.v21i6s.1539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Adolescência e Saúde, online erschienen am 17.08.2026. Verfasst von Dr. Neha K und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major depressive disorder (MDD) is one of the most common causes of disability in young adults globally, and antidepressant drug therapy is a first-line treatment for moderate-to-severe cases. Although antidepressants are effective, rates of non-adherence are significantly lower in older adults compared with non-adherence in younger adults (ages 18-25 to 18-35 years), with early discontinuation of treatment reported in up to 50% of younger adults after the first 6 months of treatment. This narrative review aims to summarize the patient-reported impediments to antidepressant adherence specific to young adults, based on qualitative, cross-sectional, and systematic review studies published in PubMed, Scopus-indexed journals and PLOS/BMC/Frontiers platforms. Six domains of barriers are identified: (1) intolerable and stigmatizing side effects, particularly sexual dysfunction, weight gain, and emotional blunting; (2) negative beliefs about the necessity to take psychiatric medication, dependency, and the “chemical imbalance” explanatory model; (3) internalized and social stigma associated with taking psychiatric medication during a developmentally identity-forming period; (4) inadequate patient-provider communication and limited shared decision-making; (5) structural and logistical barriers, including cost, insurance discontinuity, and appointment access, which disproportionately affect young adults transitioning out of their parents' coverage and pediatric care; and (6) developmental factors unique to young adulthood, such as symptom-driven self-discontinuation once feeling better, competing life transitions, and low engagement with routine follow-up. Considerations for clinical practice and methodological limitations, such as the underlying evidence base, including the heterogenicity of adherence measurement and the lack of studies limited to a narrow age range of 18-25 years, are discussed. Findings agree with multi-level adherence interventions, which are tailored to each child's developmental level, rather than single factor.

Zitieren

APA

K, D. N., Farswan, D. A., Singh, D. R., Kaur, D. R., & Meenakshi, D. (2026). Patient-Reported Barriers To Antidepressant Adherence Among Young Adults With Major Depressive Disorder: A Narrative Review. Adolescência e Saúde, 21(6s), 36-41. https://doi.org/10.67440/ahj.v21i6s.1539

Vancouver

K DN, Farswan DA, Singh DR, Kaur DR, Meenakshi D. Patient-Reported Barriers To Antidepressant Adherence Among Young Adults With Major Depressive Disorder: A Narrative Review. Adolescência e Saúde. 2026;21(6s):36-41. doi:10.67440/ahj.v21i6s.1539

BibTeX
@article{K2026,
  author = {K, Dr. Neha and Farswan, Dr Anjana and Singh, Dr. Ranjana and Kaur, Dr. Raskirat and Meenakshi, Dr.},
  title = {Patient-Reported Barriers To Antidepressant Adherence Among Young Adults With Major Depressive Disorder: A Narrative Review},
  journal = {Adolescência e Saúde},
  year = {2026},
  volume = {21},
  number = {6s},
  pages = {36--41},
  doi = {10.67440/ahj.v21i6s.1539}
}
Kostenlos starten →